Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.

The pharmacokinetics of zidovudine were evaluated in 41 patients with Centers for Disease Control HIV class IVA infection. The patients were assigned escalating doses of zidovudine (300, 600, or 1,500 mg daily) and were randomized to receive either zidovudine alone or zidovudine with a high dose of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Tartaglione, T A, Collier, A C, Opheim, K, Gianola, F G, Benedetti, J, Corey, L
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 1991
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245364/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1803995/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.11.2225
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi